Home/Filings/4/0001140361-17-045123
4//SEC Filing

GEORGIOU GEORGE 4

Accession 0001140361-17-045123

CIK 0001636282other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:01 PM ET

Size

5.8 KB

Accession

0001140361-17-045123

Insider Transaction Report

Form 4
Period: 2017-12-01
Transactions
  • Award

    Director Stock Option (right to buy)

    2017-12-01+30,00030,000 total
    Exercise: $4.73Exp: 2027-11-30Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0000749811

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:01 PM ET
Size
5.8 KB